Narrow search
Showing 1 - 10 of 2,297
Cover Image
The January effect: medication reinitiation among Medicare part D beneficiaries
Kaplan, Cameron; Zhang, Yuting - In: Health economics 23 (2014) 11, pp. 1287-1300
Persistent link: https://www.econbiz.de/10011308176
Cover Image
Pharmaceutical advertising and Medicare Part D
Lakdawalla, Darius; Sood, Neeraj; Gu, Qian - In: Journal of health economics 32 (2013) 6, pp. 1356-1367
Persistent link: https://www.econbiz.de/10010425165
Cover Image
Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs
Liu, Judith; Zhang, Yuting; Kaplan, Cameron M. - In: Health economics 32 (2023) 3, pp. 639-653
Persistent link: https://www.econbiz.de/10014266837
Cover Image
Pharmaceutical benefit scheme and cost containment in Taiwan's National Health Insurance
Huang, Weng-Foung; Chiang, Hung-Chi - In: Journal of pharmaceutical finance, economics & policy 12 (2003) 2, pp. 133-149
Persistent link: https://www.econbiz.de/10002185666
Cover Image
The impact of additive or substitutive clinical study design on the negotiated reimbursement for oncology pharmaceuticals after early benefit assessment in Germany
Dintsios, C. M.; Beinhauer, I. - In: Health economics review 10 (2020) 7, pp. 1-25
Background: We analysed the impact of clinical study design for oncological pharmaceuticals on the subsequent price … Health Insurance Funds. The analysis was conducted for all oncology pharmaceuticals that underwent the early benefit …. Further analyses should be performed when more oncology pharmaceuticals have passed the early benefit assessment. …
Persistent link: https://www.econbiz.de/10012291135
Cover Image
A Position Auction Demonstration Project for Lowering Reference + Biosimilar Drug Prices in Medicare Part B
Abrams, Lawrence - 2019
Persistent link: https://www.econbiz.de/10012863945
Cover Image
Pharmaceutical demand response to utilization management
Sarig, Oren - In: Journal of health economics 93 (2024), pp. 1-18
Persistent link: https://www.econbiz.de/10014451293
Cover Image
The economics of alternative payment models for pharmaceuticals
Hlávka, Jakub P.; Yu, Jeffrey C.; Goldman, Dana P.; … - In: The European journal of health economics 22 (2021) 4, pp. 559-569
Persistent link: https://www.econbiz.de/10012586512
Cover Image
Pricing the pharmaceuticals when the ability to pay differs
Kanniainen, Vesa; Laine, Juha; Linnosmaa, Ismo - In: Journal of the Finnish Economic Association : JFEA 2 (2021) 1, pp. 25-48
A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. This paper analyses the public insurance of a patent-protected pharmaceutical product in terms of price controls and socially optimal third-degree price discrimination. First, the paper...
Persistent link: https://www.econbiz.de/10013286496
Cover Image
Pricing the pharmaceuticals when the ability to pay differs : taking vertical equity seriously
Kanniainen, Vesa; Laine, Juha; Linnosmaa, Ismo - 2019
A non-trivial fraction of people cannot afford to buy pharmaceutical products at unregulated market prices. Therefore, the paper analyzes the public insurance of the pharmaceutical products in terms of price controls and the socially optimal third-degree price discrimination. It characterizes...
Persistent link: https://www.econbiz.de/10012157261